Skip to content

Comparison of First Attempt Success in Nasotracheal Intubation Using Macintosh Videolaryngoscope vs. Flexible Bronchoscope

Comparison of First Attempt Success in Nasotracheal Intubation Using Macintosh Videolaryngoscope vs. Flexible Bronchoscope: a Randomized Controlled Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06964295
Enrollment
74
Registered
2025-05-09
Start date
2025-05-09
Completion date
2026-05-07
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation Complication

Brief summary

Participants are randomly assigned to two groups: one group undergoes nasotracheal intubation using a videolaryngoscope, while the other group undergoes nasotracheal intubation using a flexible bronchoscope. The primary outcome is the first-attempt success rate, assessed at the time of tracheal tube placement. Additional outcomes include the degree of subglottic injury upon extubation, and the incidence and severity of sore throat and hoarseness at 1 hour and 24 hours postoperatively, as well as overall intubation success rates.

Interventions

Used to perform nasotracheal intubation under general anesthesia. The Macintosh videolaryngoscope is introduced orally to visualize the glottis, and a preformed nasotracheal tube is inserted through the nostril.

DEVICEFlexible bronchoscope

Used to perform nasotracheal intubation under general anesthesia. The bronchoscope is inserted through a lubricated nasotracheal tube and advanced into the trachea.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 19 years or older * Undergoing ear, nose, and throat (ENT) surgery requiring nasotracheal intubation

Exclusion criteria

* Refusal to participate in the study * History of gastroesophageal reflux disease * History of surgery or radiation therapy involving the upper airway * Presence of severely loose teeth

Design outcomes

Primary

MeasureTime frameDescription
First-attempt success rate of nasotracheal intubationAt the time of tracheal intubationThe proportion of patients in whom nasotracheal intubation is successfully completed on the first attempt, comparing the videolaryngoscope group with the flexible bronchoscope group.

Secondary

MeasureTime frameDescription
Degree of subglottic injuryAt the time of extubationGraded from 0 to 3 using a flexible bronchoscope. Higher scores mean a worse outcome (more severe subglottic injury).
Postoperative sore throat severity1 hour and 24 hours postoperativelyAssessed using the Numeric Rating Scale (0-10) at 1 and 24 hours after surgery.
Incidence of postoperative hoarseness1 hour and 24 hours postoperativelyPresence or absence of hoarseness evaluated at 1 hour and 24 hours postoperatively.
Cormack-Lehane gradeAt the time of tracheal intubationGrading recorded during intubation to evaluate glottic exposure.
Changes in blood pressureWithin 5 minutes before and after intubationChanges in blood pressure recorded before and after tracheal intubation.
POGO scoreAt the time of tracheal intubationVisualization scores recorded during intubation to evaluate glottic exposure. The score ranges from 0% (no glottic visualization) to 100% (full view of the glottis). Higher scores indicate a better outcome (better visualization).
Changes in heart rateWithin 5 minutes before and after intubationChanges in heart rate recorded before and after tracheal intubation.
Changes in saturationWithin 5 minutes before and after intubationChanges in SpO₂ recorded before and after tracheal intubation.
Changes in bispectral valueWithin 5 minutes before and after intubationChanges in BIS values recorded before and after tracheal intubation.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026